Trademark Overview
On Wednesday, June 5, 2024, a trademark application was filed for T with the United States Patent and Trademark Office. The USPTO has given the T trademark a serial number of 98585319. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, December 18, 2024. This trademark is owned by T-Therapeutics Limited. The T trademark is filed in the Natural Agricultural Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Software; software for use in scientific and/or pharmaceutical research and development; software for scientific modelling; software for pharmaceutical modelling; software for research and development in the field of antibodies; devices for analysing genome information; software for performing gene sequencing research and visualisation; software for the managing, analysis, and visualisation of biological data
Pharmaceutical preparations; pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes; chemical preparations for use in DNA analysis [medical]; DNA synthesis inhibitors; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use; immunotherapeutic drugs; reagents for medical use; diagnostic preparations; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; living cells for medical use; biological preparations for medical purposes, namely for T-cell therapy, gene therapy and cell therapy; biological and pharmaceutical preparations in the form of living cells for use in the treatment of immunological diseases; T-cell therapy pharmaceutical preparations; medical preparations in the nature of genetically modified immune cells for...
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmacy advice; medical and health services relating to DNA, genetics, and genetic pathogen testing; medical screening and assaying; DNA screening for medical purposes; mice breeding services; medical services relating to the removal, treatment and processing of living cells; medical services, namely treatment and preparation of living cells for medical use; cell therapy medical treatment services; medical testing in the field of cell therapy and gene therapy; medical analysis and medical consulting in connection with immunotherapy
Live laboratory mice; transgenic mice
Scientific, medical and technological services and research and design relating thereto; design and development of computer hardware and software; platform as a service [PaaS]; platform as a service [PaaS] featuring DNA analysis software; software as a service [Saas]; software as a service [Saas] featuring DNA analysis software; provision of non-downloadable software for the management, visualisation and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research purposes and diagnostic and treatment purposes; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; biomedical analysis and research services in relation to transgenic mice; preparation of biological samples for analysis and research purposes, namely living cells for biomedical use; structur...
